Not Tagged
Not Tagged
['vesper']
update on phase 3 vesper trial presented at #asco23 : ddmvac do better than gemcis (os, pfs, and disease specific survival) !
Medical oncologist, Urologic Oncology @HopitalPompidou @APHP Paris (France)